Share ownership Lumosa Therapeutics Co., Ltd.

6535

TW0006535008

Biotechnology & Medical Research

End-of-day quote Taipei Exchange Other stock markets 11/06/2026			5-day change	1st Jan Change
106.50 ^TWD	-1.39%		-9.75%	-45.24%

11/05	Lumosa Therapeutics Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2026	CI
23/02	Lumosa Therapeutics Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2025	CI

Share class: Lumosa Therapeutics Co., Ltd.

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	16,74,85,825	8,78,77,825 ( 52.47 %)	3,55,000 ( 0.212 %)	52.47 %

Major shareholders: Lumosa Therapeutics Co., Ltd.

Name	Stocks	%	Valuation
CENTER LABORATORIES, INC. 34.42 %	5,77,76,874	34.42 %	225 M NT$
Yucheng Management Consultant Co. Ltd. 0.6275 %	10,53,218	0.6275 %	4 M NT$
Te Fu Hsieh 0.29 %	4,86,724	0.29 %	2 M NT$
Wan Lai Cheng 0.2891 %	4,85,295	0.2891 %	2 M NT$
Hsueh Ling Wang 0.2827 %	4,74,511	0.2827 %	2 M NT$

Breakdown by shareholder type

Center Laboratories, Inc.	34.42%
Individuals	0.86%
Institutional	0.63%
Unknown	64.09%

Based on 1000 largest holdings

Geographical origin of shareholders

Taiwan	35.05%
Individuals	0.86%

Based on 1000 largest holdings

LUMOSA THERAPEUTICS CO., LTD. is a Taiwan-based company principally engaged in the development of new drugs. The Company is engaged in the development of new drugs for unmet medical needs in the fields of central nervous system (CNS), oncology, and inflammatory diseases. The Company is engaged in scientific licensing and new drug development under the reSEARCH and DEVELOPMENT model.

Employees

Sector

Biotechnology & Medical Research

More about the company